Use of Secondary Prevention Drugs for Cardiovascular Disease in the Community in High-Income, Middle-Income, and Low-Income Countries (The PURE Study): A Prospective Epidemiological Survey

Study Questions:

What is the use of secondary preventive drugs (antiplatelet drugs, beta-blockers, angiotensin-converting enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke in low-income and middle-income countries?